Todd Brown is an Endocrinology/Metabolic physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Baltimore, MD 212870005
Telephone
410-955-9270Registry record last updated 31 Jan 2014.
Clinical trials
- PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332)
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
Sponsor: Brown, Todd, M.D., Ph.D.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202512 payments
- ViiV Healthcare CompanyProgram year20251 payment
- EMD Serono, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
52.1%GLP-1 receptor agonist26.8%Trulicity70%Ozempic30%Part D<11 patientsSGLT2 inhibitor11.6%Jardiance100%Part D<11 patients+ 2 more classes in this area
Hormonal (systemic)
27.1%l-Thyroxine10.2%Levothyroxine Sodium100%Part D<11 patientsThyroid Hormone Synthesis Inhibitor7%Methimazole100%Part D<11 patients+ 2 more classes in this area
Genitourinary & hormones
9.9%Androgen9.9%Testosterone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
17 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
Johns Hopkins University
FY2026$3,151,791U01HL146201 - Defining cellular and molecular processes underlying adipose tissue dysfunction onINSTI-based antiretroviral therapy
Johns Hopkins University
FY2026$684,859R01DK141455 - Clinical Research and Epidemiology in Diabetes and Endocrinology
Johns Hopkins University
FY2026$230,616T32DK062707
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”